Brian Gabrielli

Australia

Research Interests

Explore related searches

Professors in Australia Professors in Immunology Immunology professors in Australia

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (6)

Year:

2025

Year:

2024

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Collaborators (11)

Mark Adams

Queensland University of Technology

AUSTRALIA

View details

Riccardo Dolcetti

Head, Clinical and Translational Immunotherapy

Peter MacCallum Cancer Centre

AUSTRALIA

View details

Ian Frazer

University of Queensland

AUSTRALIA

View details

Jazmina L. G. Cruz

University of Queensland

AUSTRALIA

View details

Pascal Duijf

Associate Professor

University of South Australia

AUSTRALIA

View details

Philip Moseley

The University of Queensland Diamantina Institute

AUSTRALIA

View details

Emma Duncan

King’s College London

UNITED KINGDOM

View details

James Wells

The University of Queensland

AUSTRALIA

View details

Alexander Stevenson

Mater Medical Research Institute

AUSTRALIA

View details

Helen Rizos

Macquarie University

AUSTRALIA

View details

Zhen Zeng

AUSTRALIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Brian Gabrielli

Research Interests

Explore related searches

Contact this professor

Articles (6)

Checkpoint Kinase 1 Inhibitor Combined with Low Dose Hydroxyurea Promotes ATM-Activated NF-κB-Dependent Pro-Inflammatory Chemokine Expression in Melanomas

The ATM Ser49Cys Variant Effects ATM Function as a Regulator of Oncogene-Induced Senescence

Checkpoint kinase 1 inhibitor + low‐dose hydroxyurea efficiently kills BRAF inhibitor‐ and immune checkpoint inhibitor‐resistant melanomas

Repurposing of Commercially Existing Molecular Target Therapies to Boost the Clinical Efficacy of Immune Checkpoint Blockade

Targeting Replication Stress Using CHK1 Inhibitor Promotes Innate and NKT Cell Immune Responses and Tumour Regression

Dysregulated G2 phase checkpoint recovery pathway reduces DNA repair efficiency and increases chromosomal instability in a wide range of tumours

Collaborators (11)

Mark Adams

Riccardo Dolcetti

Ian Frazer

Jazmina L. G. Cruz

Pascal Duijf

Philip Moseley

Emma Duncan

James Wells

Alexander Stevenson

Helen Rizos

Zhen Zeng

Make your next move.